Abstracts

Citation

Daniel H. Conway, M.D., Gwendolyn B. Scott, M.D., Daniel G. Muenz, B.A., Hans ML Spiegel, M.D., Ph.D., Susan Brogly, Ph.D., Katherine M. Knapp, M.D., Jeffrey Talbot, M.P.H., David E. Shapiro, Ph.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H. Prevalence of Congenital Anomalies in Infants with In Utero Exposure to Antiretrovirals: IMPAACT P1025. Presented at: 17th Conference on Retroviruses & Opportunistic Infections.

Citation

Kristin Baltrusaitis, Lynda Stranix-Chibanda, Grace Montepiedra, Lisa Aaron, Jyoti Mathad, Carol Onyango, Patricia Mandima, Mandisa Nyati, James Ngocho, Gift Chareka, Ponego Ponetshego, Gaerolwe Masheto, Katie McCarthy, Patrick Jean-Phillippe, Amita Gupta, IMPAACT P1078 study team. Prevalence of depression among postpartum women on Isoniazid-Preventive Therapy and Efavirenz-based treatment for HIV—An exploratory objective of the IMPAACT P1078 randomized trial. Presented at: IAS 2021.

Citation

Patricia Mandima, Kristin Baltrusaitis, Grace Montepiedra, Lisa Aaron, Jyoti Mathad, Carolyne Onyango-Makumbi, Mandisa Nyati, James Ngocho, Gift Chareka, Ponego Ponatshego, Gaerolwe Masheto, Katie McCarthy, Patrick Jean-Phillippe, Amita Gupta, Lynda Stranix-Chibanda, IMPAACT P1078 Study Team. Prevalence of depression among postpartum women on Isoniazid-Preventive Therapy and Efavirenz-based treatment for HIV—An exploratory objective of the IMPAACT P1078 randomized trial. Presented at: International Workshop on HIV Pediatrics.

Citation

John J. Farley, M.D., M.P.H., Philimon Gona, Ph.D., Marilyn Jean Crain, M.P.H., M.D., Joseph S. Cervia, M.D., F.A.C.P., F.A.A.P., Jane C. Lindsey, Sc.D., James M. Oleske, M.D. Prevalence of Hypercholesterolemia and Associated Risk Factors among Perinatally HIV-infected Children (4-19 Years) In PACTG 219c. Presented at: 10th Conference on Retroviruses & Opportunistic Infections.

Citation

Dorothy Dow, Jennifer Libous, Emma Davies Smith, Rebecca Dirschberger, Olga Varechtchouk, Sonia Lee, Tichaona Vhembo, Lynda Stranix-Chibanda, Teacler Nematadzira, Ponego Lloyd Ponatshego, Limbika Maliwichi, Tisungane Mvalo, Janice Buckley, Nicole Montañez, Geri Donenberg. Primary Findings of IMPAACT 2016: a RCT of a Youth-Led Mental Health Intervention for Youth with HIV. Presented at: CROI 2026; 2026 Feb 25.

Citation

Charles Debeaux Mitchell, M.D., George D. McSherry, M.D., Avy Violari, M.D., Mark F. Cotton, MMED, Ph.D., MB ChB, Raziya Bobat, M.D., Patrick Jean-Philippe, M.D., Sue Kim, Sharon Appelbaum Nachman, M.D. Primary Isoniazid prophylaxis did not protect against Tuberculosis or Latent TB infection in HIV-exposed, uninfected infants in South Africa. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

D Burger, E Acosta, N van Ewijk, C Taylor, P Bollen, T Ruane, A Colbers, A Turkova, R Di Francesco, G Morse, R Browne. PROFICIENCY TESTING SUPPORTS COMBINED ANALYSIS OF DOLUTEGRAVIR PHARMACOKINETIC DATA. Presented at: CROI 2019.

Citation

Vincent J. Carey, Ph.D., Adriana Weinberg, M.D., Savita G. Pahwa, M.D., Andrea Kovacs, M.D., Sandra K. Burchett, M.D., M.S. Prognostic value of 3-color flow cytometry in advanced pediatric HIV disease. Presented at: 14th Conference on Retroviruses and Opportunistic Infections.

Citation

Florence H. Yong, M.S., Kenneth Stanley, Ph.D., Ross E. McKinney, Jr., M.D., Stephen A. Spector, M.D., J. Louise Martin-Carpenter, M.S., George M. Johnson, M.D., Wendy G Mitchell, M.D., Karen J. O'Donnell, Ph.D., Pim Brouwers, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Janice Hodge, R.N., B.S. Prognostic Value of Plasma RNA, CD4 and Growth Markers for Clinical Disease Progression in Children with HIV Disease.